-
Trump travel ban comes into effect
http://www.bbc.co.uk/news/world-us-canada-40452360Not really related but, I read a story recently about the treatment one guy and his wife received when re-entering the US after a visit to family back in India to attend a funeral. They had lived in West Virginia and both highly acclaimed academics at the University there. Their children had also spent 5 solid years making friends and establishing strong links at school and beyond etc. The treatment at passport control after technical problems with passport automated check in system, was basically, you are in the wrong line, you are a visitor and no one special. Then grilled by immigration about why they were travelling back / forth to India so often. They were all mentally frazzled. But had enough.
They moved to Canada and the Uni they left gutted obviously. Now citizens in Canada and rebuilding their lives, whenever they fly back, and land in Toronto, they all receive a message that says, 'welcome home'.
-
Thanks, J, likewise!
-
The view on the Syrian sarin gas attack from the pro Russian, pro Assad media.
-
Is that true?
-
I don't think he made The Cut
-
Probably a long story but he cut it short
-
Aside from the greater message, this feels a bit insane when you read it like this:
One year after that vote, Britain is on edge. More divided than ever
after an inconclusive election, the country has lived through four
terrorist attacks in recent months — three by British Muslims and one
against them. A charred housing project where a fire killed at least
80 mostly disadvantaged tenants in one of London’s richest boroughs
has turned into a somber monument to inequality. -
The thing I find more infuriating is the misplaced anger from the cabbies. Technology happens. People exploit opportunities. These are inevitables. Cabbies should direct their anger at the shit way Uber treat their drivers (fairer pay and conditions would reduce the price disparity) and with the government that has the power to regulate if appropriate. They also need to get their ducks in a row in terms of apps and convenient payments (maybe oyster?).
The fact that cabbies seem to overwhelmingly voted for Brexit because of immigration/Uber completely misses the point and it fucks me off.
-
apps and convenient payments
and pay actual tax? you're having a giraffe.
most black cab drivers i've had the misfortune to encounter HATE uber drivers. The fact that Uber treats their drivers like shit doesn't even register. Besides, supporting your fellow worker's access to basic employment rights smacks of communism, and fuck that sky high.
-
Hackney Cabs can fuck off, what is the actual point of them anymore? The fact that they're mostly cunts makes their current predicament even sweeter... I've heard loads of them boasting about the tiny percentage of earnings they actually declare, they can all fuck off to Uber as far as I'm concerned, entitled cunts...
-
I hadn't thought of it like that, but there's an interesting parallel - if LTDA members fought for Uber drivers to be recognised as employees, and to have a decent minimum wage then as you say the price disparity may become much much smaller (unless Uber subsidises the UK market to destroy the competition, of course).
The parallel I mentioned is that if there is a strongly enforced minimum wage then there's no point hiring an immigrant to perform a task simply because they're cheap.
Labour rights, strongly enforced, would resolve what people hope to achieve by closing the borders to forrins.
-
From the FT:
UK ministers call for post-Brexit co-operation with EU on drugs
Jeremy Hunt and Greg Clark try to set out position for pharmaceutical industryUK ministers call for post-Brexit co-operation with EU on drugs Jeremy Hunt and Greg Clark try to set out position for pharmaceutical industry Read next UK civil service in turf war over Brexit Investment in life sciences currently generates more than £60bn a year for the UK economy © FT Montage Share on Twitter (opens new window) Share on Facebook (opens new window) Share on LinkedIn (opens new window) 199 Save YESTERDAY by: Sarah Neville and Jim Pickard in London Two senior UK ministers have warned hardline Brexiters they should be ready to accept some continued regulation from Brussels, writing that Britain’s life sciences sector needs collaboration with the EU’s drug regulator after Brexit. In a letter to the Financial Times, Jeremy Hunt, health secretary, and Greg Clark, business secretary, said that in order to shore up investment in the industry, “the UK would like to find a way to continue to collaborate with the EU, in the interests of public health and safety”. The ministers said the proposal was in line with prime minister Theresa May’s desire for “deep, broad and dynamic co-operation” with the EU after Britain exits. But it also takes the unusual step of publicly spelling out their negotiating position before EU divorce talks are fully under way. Pharmaceutical industry leaders have been calling for a clear outline of the government’s stance, fearing that continuing uncertainty could sap global confidence in the UK medicines sector. Investment in life sciences generates more than £60bn a year for the UK economy and supports 220,000 jobs. Some executives worry that if the UK is forced to develop its own drug approval system, divorced from the rest of the EU, Britain may find itself at the back of the queue for new medicines because drug companies will concentrate on securing approval in bigger and more lucrative markets. The ministers wrote that, if they are unable to secure “our desired relationship with the EU”, Britain would be required to “set up a regulatory system” to process drug licenses “as quickly as possible”. Health secretary Jeremy Hunt © Reuters Government insiders said the letter from Mr Hunt and Mr Clark has been signed off by Downing Street, the Treasury and the Department for Exiting the EU. However, in political circles it is likely to reinforce the perception that cabinet ministers are now prone to “freelancing” after Mrs May was weakened by the Conservatives’ disastrous general election result. The new lack of discipline has meant ministers have felt freer to express their views on Brexit in particular. Boris Johnson, foreign secretary, Philip Hammond, chancellor, and David Davis, Brexit secretary, have all set out varying visions for Britain’s post-Brexit relationship with the EU. Mr Johnson and Mr Hammond have also been part of a recent cabinet free-for-all over public sector pay. Letters The UK wants to continue to work with the EU on medicines From Jeremy Hunt, UK health secretary, and Greg Clark, UK business secretary The European Medicines Agency, based in London’s Canary Wharf, currently reviews the safety of all medicines produced in the EU. Each member state also has its own national regulatory agency. But the EU medicines agency will leave London when Britain exits the EU, creating uncertainty about whether the UK will have to develop its own freestanding system for drug approvals. Under the current system, a drug first goes through a scientific assessment phase, conducted by the EMA. The European Commission in Brussels then decides whether to authorise the medicine to be used in all member states. One option favoured by the industry would be for the UK to continue to participate in the first phase — via its national agency, the Medicines and Healthcare Products Regulatory Agency — and when a recommendation has been agreed, separate but identical proposals would be sent to Brussels and London for authorisation. This would allow the UK government to issue its own approval under domestic law that would not be governed by the European Court of Justice. Britain will have to maintain or replace the work of at least 34 European regulators after it leaves the EU, ranging from financial services, through chemicals and plastic to life sciences. Pharmaceutical industry leaders welcomed the intervention by Mr Hunt and Mr Clark. Steve Bates, chief executive of the BioIndustry Association, described the letter as “good news for patients, industry and investors”. Philip Thomson, president of global affairs at GlaxoSmithKline, said the “clear intention to prioritise patient safety and provide stability for the life science industry through the Brexit process is very welcome”. Pascal Soriot, chief executive of AstraZeneca, said securing an agreement with the EU “that enables innovative companies like ours to access scientific talent and rely on efficient supply chains as well as integrated medicines regulation will be critical to our sustainable success”. Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry, praised the government for “making the first move”, but said an agreement should be reached quickly given the industry’s very long timelines for drug development. “While I understand that the current plan is not to agree anything until everything is agreed, that just won’t work for us and therefore we would very much hope that . . . we will get an early signal in terms of the arrangements we put in place to ensure the supply of medicines,” he said.
almac68
Oliver Schick
William.
boristrump
WillMelling
chez_jay
dancing james
marcomarcos
dubtap
abr
deleted
Stonehedge
NurseHolliday
Dammit
dst2-
Post a reply
About
In the news
Posted by
@Platini
paging whatever Tibbs is calling himself these days